A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial
一项务实、多中心、双盲、安慰剂对照的随机试验,旨在评估米氮平和卡马西平治疗阿尔茨海默病伴躁动行为患者的安全性、临床疗效和成本效益:HTA-SYMBAD试验
期刊:Health Technology Assessment
影响因子:4
doi:10.3310/VPDT7105
Banerjee, Sube; Farina, Nicolas; Henderson, Catherine; High, Juliet; Stirling, Susan; Shepstone, Lee; Fountain, Julia; Ballard, Clive; Bentham, Peter; Burns, Alistair; Fox, Chris; Francis, Paul; Howard, Robert; Knapp, Martin; Leroi, Iracema; Livingston, Gill; Nilforooshan, Ramin; Nurock, Shirley; O'Brien, John; Price, Annabel; Thomas, Alan J; Swart, Ann Marie; Telling, Tanya; Tabet, Naji